Hunan Hansen Pharmaceutical Co Ltd

SHE:002412 China Drug Manufacturers - Specialty & Generic

Market Cap

$470.47 Million

CN¥3.45 Billion CNY

Market Cap Rank

#14197 Global

#3706 in China

Share Price

CN¥6.86

Change (1 day)

-1.86%

52-Week Range

CN¥5.55 - CN¥8.02

All Time High

CN¥51.53

Hunan Hansen Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 13.94%

Hunan Hansen Pharmaceutical Co Ltd (002412) has an Asset Resilience Ratio of 13.94% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥357.16 Million

Cash + Short-term Investments

Total Assets

CN¥2.56 Billion

All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how Hunan Hansen Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Hunan Hansen Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥357.16 Million	13.94%
Total Liquid Assets	CN¥357.16 Million	13.94%

Asset Resilience Insights

Moderate Liquidity: Hunan Hansen Pharmaceutical Co Ltd has 13.94% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.